Matauro LLC Has $2.11 Million Stock Position in Oscar Health, Inc. $OSCR

Matauro LLC raised its stake in Oscar Health, Inc. (NYSE:OSCR) by 58.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 111,563 shares of the company’s stock after acquiring an additional 41,249 shares during the period. Matauro LLC’s holdings in Oscar Health were worth $2,112,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. LRI Investments LLC lifted its position in Oscar Health by 377.9% in the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock valued at $26,000 after acquiring an additional 975 shares in the last quarter. Jones Financial Companies Lllp raised its stake in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio bought a new stake in shares of Oscar Health in the first quarter valued at about $30,000. Atlantic Union Bankshares Corp bought a new stake in shares of Oscar Health in the second quarter valued at about $33,000. Finally, Nisa Investment Advisors LLC boosted its position in shares of Oscar Health by 71.4% during the second quarter. Nisa Investment Advisors LLC now owns 2,658 shares of the company’s stock worth $57,000 after buying an additional 1,107 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Up 0.4%

Shares of Oscar Health stock opened at $14.87 on Friday. The stock has a market cap of $3.93 billion, a P/E ratio of -13.27 and a beta of 1.88. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The business’s 50 day moving average is $17.12 and its 200-day moving average is $17.03.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The business had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $3.09 billion. During the same period last year, the business earned ($0.22) earnings per share. The firm’s revenue was up 23.2% on a year-over-year basis. Equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

OSCR has been the topic of a number of recent research reports. Wells Fargo & Company dropped their target price on Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. The Goldman Sachs Group assumed coverage on shares of Oscar Health in a research note on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price target for the company. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $13.00 to $25.00 in a report on Tuesday, November 25th. Finally, Stephens initiated coverage on shares of Oscar Health in a research report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price for the company. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $15.57.

Insider Activity

In other news, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $121,737.42. Following the transaction, the insider directly owned 172,527 shares in the company, valued at $2,862,222.93. The trade was a 4.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Adam Mcananey sold 1,852 shares of the company’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $30,724.68. Following the completion of the sale, the insider directly owned 179,241 shares in the company, valued at approximately $2,973,608.19. The trade was a 1.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 739,472 shares of company stock worth $12,616,880. Insiders own 24.39% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.